Antimicrobial resistance patterns in long term geriatric care. Implications for drug therapy

Area of Science:

• Infectious Diseases
• Microbiology
• Healthcare Management

Background:

• Bacterial infections are prevalent in long-term care facilities, affecting 4.4% to 16.2% of residents.
• Antimicrobial resistance is a growing global health concern, complicating treatment and increasing healthcare costs.
• Nursing home environments present unique challenges for infection control due to resident vulnerability and close proximity.

Purpose of the Study:

• To review the mechanisms of antibacterial resistance.
• To focus on four major antibacterial-resistant bacteria commonly found in nursing homes.
• To highlight essential infection control practices for long-term care facilities.

Main Methods:

• Literature review of antibacterial resistance mechanisms.
• Discussion of specific resistant pathogens: methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), multidrug-resistant Gram-negative bacilli, and Streptococcus pneumoniae.
• Emphasis on diagnostic testing and treatment considerations.

Main Results:

• Vancomycin is the primary treatment for MRSA; colonization eradication is often unnecessary.
• High-level resistance testing is vital for enterococcal infections; vancomycin-resistant enterococci necessitate infectious disease consultation.
• Multidrug resistance is a significant issue in Gram-negative bacilli and Streptococcus pneumoniae, requiring susceptibility testing for appropriate therapy.

Conclusions:

• Implementing infection control measures such as handwashing and barrier precautions is paramount.
• Minimizing hospitalizations and staff rotation can help prevent the spread of resistant organisms.
• A comprehensive approach to infection control is necessary to combat antimicrobial resistance in nursing homes.